Use este identificador para citar ou linkar para este item: http://hdl.handle.net/1843/56589
Tipo: Artigo de Periódico
Título: Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: a scottish population-based study
Autor(es): Renata Cristina Rezende Macedo do Nascimento
Marion Bennie
Amanj Kurdi
Tanja Mueller
Brian Godman
Sean Macbride Stewart
Simon Hurding
Francisco Assis Acurcio
Augusto Afonso Guerra Júnior
Juliana Alvares Teodoro
Alec Morton
Resumo: Aim: To assess associations between statin intensity and adherence, persistence and discontinuation of statin therapy in Scotland. Method: Retrospective cohort study, using linked electronic health records covering a period from January 2009 to December 2016. The study cohort included adult patients (≥18 years) newly initiating statins within Greater Glasgow and Clyde, Scotland. Study outcomes comprised adherence, discontinuation and persistence to treatment, stratified by three exposure groups (high, moderate and low intensity). Discontinuation and persistence were calculated using the refill-gap and anniversary methods, respectively. Proportion of days covered (PDC) was used as a proxy for adherence. Kaplan-Meier survival curves and Cox proportional hazard models were used to evaluate discontinuation, and associations between adherence/persistence and statin intensity were assessed using logistic regression. Results: A total of 73 716 patients with a mean age of 61.4 ± 12.6 years were included; the majority (88.3%) received moderate intensity statins. Discontinuation rates differed between intensity levels, with high-intensity patients less likely to discontinue treatment compared to those on moderate intensity (prior cardiovascular disease [CVD]: HR 0.43 [95% CI 0.34-0.55]; no prior CVD: 0.80 [0.74-0.86]). Persistence declined over time, and high-intensity patients had the highest persistence rates. Overall, 52.6% of patients were adherent to treatment (PDC ≥ 80%), but adherence was considerably higher among high-intensity patients (63.7%). Conclusion: High-intensity statins were associated with better persistence and adherence to treatment, but overall long-term persistence and adherence remain a challenge, particularly among patients without prior CVD. This needs addressing
Assunto: Sistema cardiovascular - Doenças
Escócia
Estatinas (Agentes cardiovasculares)
Idioma: por
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Instituição: UFMG
Departamento: FAR - DEPARTAMENTO DE FARMÁCIA SOCIAL
Tipo de Acesso: Acesso Aberto
Identificador DOI: https://doi.org/10.1111/bcp.14333
URI: http://hdl.handle.net/1843/56589
Data do documento: 2020
metadata.dc.url.externa: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14333
metadata.dc.relation.ispartof: British Journal of Clinical Pharmacology
Aparece nas coleções:Artigo de Periódico



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.